CAR T Cell Locomotion in Solid Tumor Microenvironment

The promising outcomes of chimeric antigen receptor (CAR) T cell therapy in hematologic malignancies potentiates its capability in the fight against many cancers. Nevertheless, this immunotherapy modality needs significant improvements for the treatment of solid tumors. Researchers have incrementall...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Duy T., Ogando-Rivas, Elizabeth, Liu, Ruixuan, Wang, Theodore, Rubin, Jacob, Jin, Linchun, Tao, Haipeng, Sawyer, William W., Mendez-Gomez, Hector R., Cascio, Matthew, Mitchell, Duane A., Huang, Jianping, Sawyer, W. Gregory, Sayour, Elias J., Castillo, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221866/
https://www.ncbi.nlm.nih.gov/pubmed/35741103
http://dx.doi.org/10.3390/cells11121974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221866/
https://www.ncbi.nlm.nih.gov/pubmed/35741103
http://dx.doi.org/10.3390/cells11121974

Ejemplares similares